相似文献
1
Clinical insights into paraneoplastic cerebellar degeneration.
J Neurol Neurosurg Psychiatry. 2006 Apr;77(4):529-30. doi: 10.1136/jnnp.2005.082206.
2
Cerebellar hypermetabolism in paraneoplastic cerebellar degeneration.
J Neurol Neurosurg Psychiatry. 2006 Apr;77(4):525-8. doi: 10.1136/jnnp.2005.075325.
3
Strategies in detection of the primary tumour in anti-Yo associated paraneoplastic cerebellar degeneration.
J Neurol. 2005 Feb;252(2):197-201. doi: 10.1007/s00415-005-0635-0.
4
A rare case of paraneoplastic cerebellar degeneration discovered by whole-body F-18 FDG PET.
Clin Nucl Med. 2005 Oct;30(10):704-6. doi: 10.1097/01.rlu.0000178247.44467.f5.
5
Paraneoplastic cerebellar degeneration preceding the diagnosis of Hodgkin's lymphoma.
Neth J Med. 2006 Jul-Aug;64(7):243-7.
6
Diffuse cerebellar MR imaging changes in anti-Yo positive paraneoplastic cerebellar degeneration.
J Neurol. 2010 Mar;257(3):490-1. doi: 10.1007/s00415-009-5407-9. Epub 2009 Nov 27.
7
Diagnosis of Dual Malignancy by 18F-FDG PET/CT in the Setting of Paraneoplastic Cerebellar Degeneration.
J Nucl Med Technol. 2016 Mar;44(1):52-3. doi: 10.2967/jnmt.115.158659. Epub 2015 Aug 13.
8
Brain 18F-FDG-PET characteristics in patients with paraneoplastic neurological syndrome and its correlation with clinical and MRI findings.
Nucl Med Commun. 2014 Oct;35(10):1038-46. doi: 10.1097/MNM.0000000000000163.
9
Paraneoplastic cerebellar degeneration associated with cerebellar hypermetabolism: Case report.
Medicine (Baltimore). 2018 Jun;97(24):e10717. doi: 10.1097/MD.0000000000010717.
10
Paraneoplastic cerebellar degeneration in pediatric Hodgkin disease.
Neuropediatrics. 2000 Feb;31(1):42-4. doi: 10.1055/s-2000-15297.
引用本文的文献
1
PET/CT and Paraneoplastic Syndromes: A Comprehensive Review.
Cancers (Basel). 2025 Aug 13;17(16):2637. doi: 10.3390/cancers17162637.
2
Paraneoplastic Cerebellar Degeneration Associated with Breast Cancer: A Case Report and a Narrative Review.
Brain Sci. 2024 Feb 14;14(2):176. doi: 10.3390/brainsci14020176.
3
[Paraneoplastic subacute degeneration of the cerebellum in non-small cell lung cancer and positive anti-Tr3 antibodies].
Nervenarzt. 2020 Feb;91(2):156-160. doi: 10.1007/s00115-019-00859-y.
4
Paraneoplastic cerebellar degeneration with anti-Yo antibodies - a review.
Ann Clin Transl Neurol. 2016 Jun 30;3(8):655-63. doi: 10.1002/acn3.328. eCollection 2016 Aug.
5
Paraneoplastic cerebellar degeneration as a marker of endometrial cancer recurrence.
BMJ Case Rep. 2016 May 18;2016:bcr2016215286. doi: 10.1136/bcr-2016-215286.
6
Paraneoplastic cerebellar degeneration and dermatomyositis as first manifestations of underlying breast malignancy: a report of two cases and a brief review of the subject.
Surg Case Rep. 2015;1(1):59. doi: 10.1186/s40792-015-0063-z. Epub 2015 Jul 16.
7
Consensus paper: radiological biomarkers of cerebellar diseases.
Cerebellum. 2015 Apr;14(2):175-96. doi: 10.1007/s12311-014-0610-3.
8
Anti-yo associated paraneoplastic cerebellar degeneration in a man with large cell cancer of the lung.
Case Rep Neurol Med. 2013;2013:725936. doi: 10.1155/2013/725936. Epub 2013 Sep 19.
9
Paraneoplastic cerebellar degeneration mimicking acute post-infectious cerebellitis.
Cerebellum. 2009 Dec;8(4):441-4. doi: 10.1007/s12311-009-0128-2.
10
Role of FDG-PET in the clinical management of paraneoplastic neurological syndrome: detection of the underlying malignancy and the brain PET-MRI correlates.
Mol Imaging Biol. 2008 May-Jun;10(3):131-7. doi: 10.1007/s11307-008-0134-7. Epub 2008 Feb 23.
本文引用的文献
1
FDG-PET improves tumour detection in patients with paraneoplastic neurological syndromes.
Brain. 2004 Oct;127(Pt 10):2331-8. doi: 10.1093/brain/awh247. Epub 2004 Sep 10.
2
Recommended diagnostic criteria for paraneoplastic neurological syndromes.
J Neurol Neurosurg Psychiatry. 2004 Aug;75(8):1135-40. doi: 10.1136/jnnp.2003.034447.
3
Paraneoplastic syndromes involving the nervous system.
N Engl J Med. 2003 Oct 16;349(16):1543-54. doi: 10.1056/NEJMra023009.
4
Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients.
Brain. 2003 Jun;126(Pt 6):1409-18. doi: 10.1093/brain/awg133.
5
Anti-Yo antibody-positive cerebellar degeneration associated with endometrial carcinoma: case report and review of the literature.
Clin Oncol (R Coll Radiol). 2001;13(6):476-9. doi: 10.1053/clon.2001.9318.
6
Paraneoplastic cerebellar degeneration: neurological symptoms pointing to occult ovarian cancer.
Gynecol Obstet Invest. 2001;52(2):145-6. doi: 10.1159/000052961.
7
Long-term clinical outcome of paraneoplastic cerebellar degeneration and anti-Yo antibodies.
Neurology. 2000 Sep 12;55(5):713-5. doi: 10.1212/wnl.55.5.713.
8
Anti-Yo positive paraneoplastic cerebellar degeneration associated with ovarian carcinoma: case report and review of the literature.
Gynecol Oncol. 1999 Oct;75(1):178-83. doi: 10.1006/gyno.1999.5553.
9
Paraneoplastic cerebellar degeneration: a clinical comparison of patients with and without Purkinje cell cytoplasmic antibodies.
Mayo Clin Proc. 1990 Nov;65(11):1423-31. doi: 10.1016/s0025-6196(12)62166-1.
10
Paraneoplastic cerebellar degeneration. I. A clinical analysis of 55 anti-Yo antibody-positive patients.
Neurology. 1992 Oct;42(10):1931-7. doi: 10.1212/wnl.42.10.1931.
Zotero 插件